![System.Func`1[System.String]](/siteassets/images/z-mckesson-logosicons/health-systems2.png)
Our Specialty Pharmacy Enablement (SPE) expert discusses 3 critical areas of access for the health system specialty pharmacy.
How Biosimilars Differ from Biologics in Cost and Benefits
Increased affordability of biosimilars may have an impact on healthcare systems.
By
Date
August 01, 2022
By: McKesson Medical Surgical Editorial Team
Read time: 1 minute
An overview of biosimilars and how they compare to biologics
Health systems and clinics considering the adoption of biosimilars for treatment should understand and consider how they compare to biologics. Biosimilar products are therapies that have the same therapeutic value and potency as their biologic counterparts, the use of biosimilar drugs may save money for both patients and providers. Increased affordability of the biosimilars may also have a meaningful impact on the healthcare system.
To learn more, read What are biosimilars? How biosimilars differ from biologics in cost & benefits.
Subscribe Now
To learn how McKesson can help health systems achieve more, sign up to have the Prescribed Perspectives newsletter delivered directly to your inbox.
Related Stories
The most downloaded content by health system pharmacy leaders in August 2025.
With available labor resources dwindling and a shrinking pipeline, health systems must find creative solutions for better using the personnel and partnerships they have.
As payer dynamics shift, therapy pipelines grow, and leakage accelerates, health systems leaders should rethink what infusion care can and should be.
At this year's event, our experts heard from health systems who may be underutilizing available tools and resources in 340B program management.
Click through this interactive experience for a closer look at what you can expect at this year’s HealthTrust University Conference.
Our experts continue shaping industry conversations through regular conference and event engagements, like the HealthTrust University 340B Summit.
The most downloaded content by health system pharmacy leaders in July 2025.
A recent podcast includes first-hand insights on opportunities for collaboration in strengthening the supply chain to achieve more.
This interactive experience highlights key aspects of our SPE solutions, designed to help your health system achieve more.